4//SEC Filing
HAMED KAMAL 4
Accession 0000899243-22-031094
CIK 0001701108other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:49 PM ET
Size
5.1 KB
Accession
0000899243-22-031094
Insider Transaction Report
Form 4
HAMED KAMAL
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-12+210,000→ 210,000 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on September 12, 2023, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001946366
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 9:49 PM ET
- Size
- 5.1 KB